Bank of America’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-65,967
Closed -$179K 6174
2025
Q4
$179K Sell
65,967
-159,705
-71% -$524K ﹤0.01% 5391
2025
Q3
$955K Sell
225,672
-221,533
-50% -$974K ﹤0.01% 5360
2025
Q2
$2.23M Buy
447,205
+119,084
+36% +$517K ﹤0.01% 4674
2025
Q1
$1.45M Buy
328,121
+178,424
+119% +$837K ﹤0.01% 4959
2024
Q4
$696K Sell
149,697
-269,320
-64% -$1.48M ﹤0.01% 5306
2024
Q3
$2.91M Buy
419,017
+159,295
+61% +$1.25M ﹤0.01% 4234
2024
Q2
$2.03M Sell
259,722
-347,255
-57% -$2.57M ﹤0.01% 4435
2024
Q1
$4.31M Buy
606,977
+203,040
+50% +$1.34M ﹤0.01% 3758
2023
Q4
$2.71M Buy
403,937
+34,701
+9% +$195K ﹤0.01% 4094
2023
Q3
$2.08M Sell
369,236
-153,546
-29% -$1.02M ﹤0.01% 4210
2023
Q2
$2.89M Sell
522,782
-190,845
-27% -$1.03M ﹤0.01% 3895
2023
Q1
$4.46M Sell
713,627
-66,963
-9% -$373K ﹤0.01% 3635
2022
Q4
$3.64M Buy
780,590
+157,007
+25% +$773K ﹤0.01% 3705
2022
Q3
$2.91M Sell
623,583
-594,271
-49% -$3.75M ﹤0.01% 3929
2022
Q2
$7.21M Buy
1,217,854
+772,957
+174% +$8.6M ﹤0.01% 3004
2022
Q1
$8.6M Buy
444,897
+54,735
+14% +$1.26M ﹤0.01% 3011
2021
Q4
$12.8M Buy
390,162
+318,950
+448% +$12.8M ﹤0.01% 2685
2021
Q3
$2.92M Sell
71,212
-74,113
-51% -$2.69M ﹤0.01% 4089
2021
Q2
$5.23M Buy
145,325
+84,677
+140% +$3.12M ﹤0.01% 3470
2021
Q1
$2.37M Buy
60,648
+16,147
+36% +$726K ﹤0.01% 4115
2020
Q4
$1.79M Buy
44,501
+44,356
+30,590% +$2.04M ﹤0.01% 4044
2020
Q3
$8K Buy
+145
New +$7.68K ﹤0.01% 6501

Other funds holding GDRX

Bank of America's GDRX Position: Q1 2026 in Review

Bank of America sold out of GoodRx Holdings (GDRX) in Q1 2026, closing a stake of 65,967 shares — an estimated $179K sold.

Bank of America first reported a position in GDRX in Q3 2020 and held it in 22 quarters. The position peaked at $12.8M in Q4 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Bank of America reported no remaining GoodRx Holdings position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 65,967 GoodRx Holdings shares in Q1 2026, an estimated $179K.
  • Bank of America first reported a position in GoodRx Holdings in Q3 2020 and held it in 22 quarters.
  • Bank of America's GoodRx Holdings position peaked at $12.8M in Q4 2021.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.